| Entry |
|
|---|
| Name |
Oxprenolol (INN);
Oxprenolol (TN)
|
|---|
| Formula |
C15H23NO3
|
|---|
| Exact mass |
265.1678
|
|---|
| Mol weight |
265.348
|
|---|
| Structure |
     |
|---|
| Activity |
beta-Adrenergic blocking
|
|---|
| Remark |
|
|---|
| Target |
beta1-adrenergic receptor antagonist [HSA: 153] [KO: K04141]; beta2-adrenergic receptor antagonist [HSA: 154] [KO: K04142]; beta3-adrenergic receptor antagonist [HSA: 155] [KO: K04143] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA02 Oxprenolol
D08318 Oxprenolol (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Oxprenolol [ATC:C07AA02]
D08318 Oxprenolol (INN)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Oxprenolol [ATC:C07AA02]
D08318 Oxprenolol (INN)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Oxprenolol [ATC:C07AA02]
D08318 Oxprenolol (INN)
 |
|---|
| Other DBs |
CAS: 6452-71-7 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 19
1 C8x C 18.6900 -16.5200
2 C8x C 18.6900 -15.1200
3 C8x C 19.9500 -14.4200
4 C8x C 21.1400 -15.1200
5 C8y C 21.1400 -16.5200
6 C8y C 19.9500 -17.2200
7 O2a O 22.3300 -17.2200
8 C1b C 23.5200 -16.5200
9 C1c C 24.7800 -17.2200
10 C1b C 25.9700 -16.5200
11 N1b N 27.1600 -17.2200
12 C1c C 28.4200 -16.5200
13 C1a C 29.6100 -17.2200
14 O1a O 24.7800 -18.6200
15 C1a C 28.4200 -15.1200
16 O2a O 19.9500 -18.6200
17 C1b C 21.1400 -19.3200
18 C2b C 21.1400 -20.7200
19 C2a C 22.3300 -21.4200
BOND 19
1 2 3 1
2 9 10 1
3 3 4 2
4 10 11 1
5 4 5 1
6 11 12 1
7 5 6 2
8 12 13 1
9 6 1 1
10 9 14 1
11 12 15 1
12 5 7 1
13 6 16 1
14 16 17 1
15 7 8 1
16 17 18 1
17 1 2 2
18 18 19 2
19 8 9 1
|
|---|
